PLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received ...

PLC (LON:4BB – Get Free Report) insider Heikki Lanckriet purchased 2,400 shares of the business’s stock in a transaction that occurred on Wednesday, April 2nd. The stock was acquired at an average ...

Wednesday that it has received Good Manufacturing Practice (GMP) certification from the UK’s Medicines and Healthcare ...

Shares of 4basebio stock opened at GBX 1,140 ($14.77) on Thursday. The business has a fifty day simple moving average of GBX 1,168.09 and a two-hundred day simple moving average of GBX 1,267.09.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Director Dealing. Cambridge, UK, 4 April 2025 – 4basebio PLC (AIM: 4BB), an innovation-led provider of novel synthetic DNA products an ...

PLC ("4basebio" or the "Company") 4basebio Receives GMP Licence for its UK DNA Manufacturing Facility. Cambridge, UK, 2 April 2025 – 4basebio PLC (AIM: 4BB), an innovat ...

4basebio PLC has been granted Good Manufacturing Practice (GMP) certification by the UK’s Medicines and Healthcare products ...